Nasdaq · Healthcare
CURIS INC (CRIS)
As-reported financials and recent SEC filings for CURIS INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$9.4M
Net income
$-7.6M
Net margin
-80.3%
Diluted EPS
$-0.58
ROE
-138.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $9.4M | $10.9M | $10.0M | $10.2M | $10.6M |
| Gross profit | — | — | — | — | — |
| Operating income | $-5.7M | $-44.5M | $-48.3M | $-53.0M | $-42.1M |
| Net income | $-7.6M | $-43.4M | $-47.4M | $-56.7M | $-45.4M |
| Diluted EPS | $-0.58 | $-3.44 | $-4.48 | $-6.07 | $5.00 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-07-02
View on EDGAR →8-K/A2026-07-01
View on EDGAR →8-K2026-07-01
View on EDGAR →8-K2026-06-25
View on EDGAR →DEF 14A2026-06-05
View on EDGAR →PRE 14A2026-05-22
View on EDGAR →8-K2026-05-22
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →Largest Healthcare peers
Go deeper on CRIS
Search CURIS INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.